Adimmune continues patient enrolment for Phase III trial of Quadrivalent Influenza Vaccine

Asian flu vaccine provider Adimmune is continuing with patient enrolment for its Phase III trial of Quadrivalent Influenza Vaccine in Europe.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news